国际眼科纵览 ›› 2025, Vol. 49 ›› Issue (6): 447-454.doi: 10. 3760/cma.j.cn115500-20250620-25606

• 综述 • 上一篇    下一篇

细胞焦亡参与糖尿病相关眼病发生发展的研究进展

张晓光1   李元彬2   

  1. 1 滨州医学院第二临床医学院,山东烟台 264000; 2 烟台毓璜顶医院眼科,山东烟台 264000
  • 收稿日期:2025-06-20 出版日期:2025-12-22 发布日期:2025-12-22
  • 通讯作者: 李元彬,Email:yuanbinli@yeah.net
  • 基金资助:
    山东省自然科学基金(ZR2023QH479);烟台市科技创新发展计划基础研究类项目(2024YT06000766)

Research progress on the role of pyroptosis in the occurrence and development of diabetes-related eye diseases #br#

Zhang Xiaoguang 1 , Li Yuanbin 2#br#   

  1. 1The Second Clinical College of Binzhou Medical University, Yantai Shandong 264000 China; 2Department of Ophthalmology, Yantai Yuhuangding Hospital, Yantai Shandong 264000, China
  • Received:2025-06-20 Online:2025-12-22 Published:2025-12-22
  • Contact: Li Yuanbin: Email:yuanbinli@yeah.net
  • Supported by:
     Natural Science Foundation of Shandong Province (ZR2023QH479); Yantai Science and Technology Innovation Development Plan-Basic Research Project (2024YT06000766)

摘要: 糖尿病相关眼部并发症包括糖尿病视网膜病变、糖尿病性角膜病变、糖尿病性白内障等,会严重损害患者视觉质量。细胞焦亡作为一种以炎症为特征的程序性细胞死亡方式,在这些疾病的发生发展过程中发挥关键作用。核苷酸结合寡聚化结构域样受体热蛋白结构域3炎性小体激活在细胞焦亡过程中发挥着关键作用,细胞焦亡通过炎症小体激活、促炎因子释放引发眼部组织损伤视网膜、角膜、晶状体等,加速糖尿病相关眼病进展。细胞焦亡抑制剂(如 MCC950、骨化三醇、冬凌草甲素、双硫仑等)可通过抑制炎性小体的激活减轻眼部炎性反应,改善疾病预后。

关键词: 糖尿病相关眼病, 核苷酸结合寡聚化结构域样受体热蛋白结构域3, 焦亡蛋白, 细胞焦亡, 焦亡抑制剂

Abstract: Diabetes-related ocular complications—such as diabetic retinopathy, diabetic keratopathy, and diabetic cataracts—can severely impair patients' vision. Pyroptosis, an inflammatory type of programmed cell death, plays a critical role in the onset and progression of these disorders. The activation of the NLRP3 (NOD-like receptor pyrin domain 3) inflammasome is central to the pyroptotic process. Through inflammasome activation and the release of pro-inflammatory cytokines, pyroptosis contributes to damage in ocular tissues including the retina, cornea, and lens, thereby accelerating the progression of diabetes-related eye diseases. Inhibitors of pyroptosis, such as MCC950, calcitriol, oridonin, and disulfiram, have been shown to alleviate ocular inflammation by suppressing inflammasome activation, offering potential for improved clinical outcomes.

Key words: Diabetes-related eye diseases, Nucleotide-binding oligomerization domain-like receptor pyrin domain 3(NLRP3), Gasdermin D(GSDMD), Pyroptosis, Pyroptosis inhibitor